Skip to main content
SpringerLink
Log in

Congenital deficiencies in α2-antiplasmin

  • III. Proteins Inhibiting Coagulation and Fibrinolysis
  • Published:
Ricerca in clinica e in laboratorio

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brommer E. J. P., Gevers Leuven J. A., Kluft C., Wijngaards G.: Fibrinolytic inhibitor in type II hyperlipoproteinaemia—Lanceti, 1066, 1982.

    Article  Google Scholar 

  2. Clemmensen I.: Different molecular forms of α2-antiplasmin. In:Collen D., Wiman B., Verstraete M. (Eds). The physiological inhibitors of coagulation and fibrinolysis. Elsevier-North Holland, Amsterdam, 1979; p. 131.

    Google Scholar 

  3. Collen D.: Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma—Europ. J. Biochem.69, 209, 1976.

    Article  PubMed  CAS  Google Scholar 

  4. Collen D., Wiman B.: Fast-acting plasmin inhibitor in human plasma—Blood,51, 563, 1978.

    PubMed  CAS  Google Scholar 

  5. Collen D., Wiman B.: Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma. —Blood,53, 313, 1979.

    PubMed  CAS  Google Scholar 

  6. Gallimore M. J., Amundsen E., Aasen A. O., Larsbraaten M., Lyngaas K., Svendsen L.: Studies on plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate—Thrombos. Res.,14, 51, 1979.

    Article  CAS  Google Scholar 

  7. Heimburger N., Haupt H., Schwick H. G.: Proteinase inhibitors of human plasma. In:Fritz H. (Ed.), Proceedings of the International Research Conference on Proteinase Inhibitors. Walter de Gruyter, New York, 1971; p. 1.

    Google Scholar 

  8. Ichinose A., Tamaki T., Aoki N.: Factor XIII-mediated cross-linking of NH2-terminal peptide of α2-antiplasmin inhibitor to fibrin—FEBS Letters153, 369, 1983.

    Article  PubMed  CAS  Google Scholar 

  9. Kluft C., Jie A. F. H., Los P., Dooijewaard G., Traas D. W.: Expression of the two forms of α2-antiplasmin in functional and immunochemical assays. In:Davidson J. F., Bachmann F., Bouvier C. A., Kruithof E. K. O. (Eds) Progress in chemical fibrinolysis. Churchill and Livingstone, Edinburgh, 1983; vol. 6, p. 386.

    Google Scholar 

  10. Kluft C., Los, N.: Demonstration of two forms of α2-antiplasmin in plasma by modified crossed immunoelectrophoresis—Thrombos. Res.21, 65, 1981.

    Article  CAS  Google Scholar 

  11. Kluft C., Los P., Jie A. F. H.: The molecular form of α2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII—Thrombos. Res.,33, 419, 1984.

    Article  CAS  Google Scholar 

  12. Kluft C., Los P., Jie A. F. H., Van Hinsbergh V. W. M., Vellenga E.: The mutual relation between the two molecular forms of α2-antiplasmin in blood—Thrombos Haemost.50, 170, 1983.

    Google Scholar 

  13. Kluft C., Vellenga E., Brommer E. J. P., Wijngaards G.: A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of α2-antiplasmin—Blood59, 1169, 1982.

    PubMed  CAS  Google Scholar 

  14. Koie K., Ogata K., Kamiya T., Takamatsu J., Kohakura M.: α2-antiplasmin inhibitor deficiency (Miyasato disease)—Lancetii, 1334, 1978.

    Article  Google Scholar 

  15. Matsuda M., Wakabayashi K., Aoki N., Morioka Y.: α2-antiplasmin inhibitor is among acute-phase reactants—Thrombos. Res.,17, 527, 1980.

    Article  CAS  Google Scholar 

  16. Miles L. A., Plow E. F., Donnelly K. J., Hougie C., Griffin J. H.: A bleeding disorder due to deficiency of α2-antiplasmin—Blood59, 1246, 1982.

    PubMed  CAS  Google Scholar 

  17. Moroi M., Acki N.: Isolation and characterization of α2-antiplasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J. biol. Chem.251, 5956, 1976.

    PubMed  CAS  Google Scholar 

  18. Müllertz S., Clemmensen, I.: The primary inhibitor of plasmin in human plasma—Biochem. J.,159, 545, 1976.

    PubMed  Google Scholar 

  19. Nieuwenhuis H. K., Kluft C., Wijngaards G., Van Berkel W., Sixma J. J.: α2-antiplasmin Enschede: an autosomal recessive hemorrhagic disorder caused by a dysfunctional α2-antiplasmin molecule—Thrombos. Haemost.50, 170, 1983.

    Google Scholar 

  20. Saito H., Goodnough L. T., Knowles B. B., Aden D. P.: Synthesis and secretion of α2-antiplasmin inhibitor by established human liver cell lines—Proc. nat. Acad. Sci. (Wash.)79, 5684, 1982.

    Article  CAS  Google Scholar 

  21. Sakata Y., Aoki N.: Cross-linking of α2-antiplasmin inhibitor to fibrin by fibrin-stabilizing factor—J. clin. Invest.65, 290, 1980.

    Article  PubMed  CAS  Google Scholar 

  22. Samama M., Schlegel N., Cazenave B., Horellon M. H., Conard J., Castel M., Douenias R.: α2-antiplasmin assay: amidolytic and immunological method. Critical evaluation. Results in a clinical material. In:Lijnen H. R., Collen D., Verstraete M. (Eds.): Synthetic substrates in clinical blood coagulation assays. Martinus Nijhoff, The Hague, 1980; p. 93.

    Google Scholar 

  23. Sasaki T., Morita T., Iwanaga S.: Identification of the plasminogen-binding site of human α2-antiplasmin inhibitor—Thrombos. Haemost.50, 170, 1983.

    Google Scholar 

  24. Stormorken H., Gogstad G., Brosstad F.: Hereditary α2-antiplasmin deficiency. In:Jespersen J., Kluft C., Korsgaard O. (Eds): Clinical aspects of fibrinolysis and thrombolysis. South Jutland University Press, Esbjerg, 1983; p. 185.

    Google Scholar 

  25. Wiman B., Collen D.: Molecular mechanism of physiological fibrinolysis. —Nature (Lond.)272, 549, 1978.

    Article  CAS  Google Scholar 

  26. Yoshioka A., Kamitsuj H., Takase T., Iida Y., Tsukada S., Mikami S., Fukui H.: Congenital deficiency of α2-antiplasmin inhibitor in three sisters—Haemostasis11, 176, 1982.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gaubius Institute, Health Research Division TNO, Herenstraat 5d, 2313, Leiden, AD, The Netherlands

    Cornelis Kluft

  2. Department of Haematology, University Hospital Utrecht, Utrect, The Netherland

    H. Karel Nieuwenhuis

  3. Division of Haematology, Department of Medicine, University Hospital Groningen, Goringen, The Netherland

    Edo Vellenga

Authors
  1. Cornelis Kluft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Karel Nieuwenhuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edo Vellenga
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by the Praeventiefonds', project no. 28-443.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kluft, C., Nieuwenhuis, H.K. & Vellenga, E. Congenital deficiencies in α2-antiplasmin. La Ricerca Clin. Lab. 14, 507–513 (1984). https://doi.org/10.1007/BF02904878

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02904878

Key-words

Search

Navigation